Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Mesothelioma: closer to the target?

Pass HI.

Lancet Oncol. 2013 May;14(6):448-9. doi: 10.1016/S1470-2045(13)70139-6. Epub 2013 Apr 12. No abstract available.

PMID:
23583605
2.

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.

Buikhuisen WA, Burgers JA, Vincent AD, Korse CM, van Klaveren RJ, Schramel FM, Pavlakis N, Nowak AK, Custers FL, Schouwink JH, Gans SJ, Groen HJ, Strankinga WF, Baas P.

Lancet Oncol. 2013 May;14(6):543-51. doi: 10.1016/S1470-2045(13)70125-6. Epub 2013 Apr 12.

PMID:
23583604
3.

A new standard for malignant pleural mesothelioma.

Zauderer MG.

Lancet. 2016 Apr 2;387(10026):1352-1354. doi: 10.1016/S0140-6736(15)01311-2. Epub 2015 Dec 21. No abstract available.

4.

Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.

Blomberg C, Nilsson J, Holgersson G, Edlund P, Bergqvist M, Adwall L, Ekman S, Brattström D, Bergström S.

Anticancer Res. 2015 May;35(5):2493-501. Review.

PMID:
25964522
5.

Chemotherapy for malignant pleural mesothelioma.

Tomek S, Manegold C.

Curr Opin Oncol. 2003 Mar;15(2):148-56. Review.

PMID:
12601280
6.

[The role of systemic therapies of non-small cell lung cancer and malignant pleural mesothelioma: updated expert recommendations].

Jassem J, Biernat W, Bryl M, Chorostowska-Wynimko J, Dziadziuszko R, Krawczyk P, Kordek R, Kowalski DM, Krzakowski M, Olszewski W, Orłowski T, Ramlau R, Rzyman W.

Pneumonol Alergol Pol. 2014;82(2):133-49. doi: 10.5603/PiAP.2014.0019. Review. Polish.

7.

Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?

Signorelli D, Macerelli M, Proto C, Vitali M, Cona MS, Agustoni F, Zilembo N, Platania M, Trama A, Gallucci R, Ganzinelli M, Pelosi G, Pastorino U, de Braud F, Garassino MC, Lo Russo G.

Tumori. 2016 Jan-Feb;102(1):18-30. doi: 10.5301/tj.5000436. Epub 2015 Oct 14. Review.

PMID:
26481865
8.

Thalidomide in patients with malignant pleural mesothelioma.

Baas P, Boogerd W, Dalesio O, Haringhuizen A, Custers F, van Zandwijk N.

Lung Cancer. 2005 May;48(2):291-6. Epub 2004 Dec 15.

PMID:
15829331
9.

Role of conservative (palliative) care-only in the management of advanced malignant pleural mesothelioma.

Levy A, Assouline A, Rivera S, Chargari C, Tai P.

Anticancer Res. 2012 Sep;32(9):4025-7. Erratum in: Anticancer Res. 2012 Nov;32(11):5136.

PMID:
22993354
10.

Treatment of six cases of mesothelioma with doxorubicin and cisplatin.

Zidar BL, Pugh RP, Schiffer LM, Raju RN, Vaidya KA, Bloom RL, Horne D, Baker LH.

Cancer. 1983 Nov 15;52(10):1788-91.

11.

Hyperthermia: has its time come?

Smythe WR, Mansfield PF.

Ann Surg Oncol. 2003 Apr;10(3):210-2. No abstract available.

PMID:
12679303
12.

Effective chemotherapy based on a chemosensitivity test for malignant pleural mesothelioma.

Maniwa Y, Yoshimura M, Takata M, Nishimura Y, Ohno Y.

Ann Thorac Cardiovasc Surg. 2008 Oct;14(5):319-21.

PMID:
18989249
13.

Chemotherapy of malignant pleural mesothelioma.

Bertino P, Carbone M, Pass H.

Expert Opin Pharmacother. 2009 Jan;10(1):99-107. doi: 10.1517/14656560802631285 . Review.

PMID:
19236184
14.

Deciduoid pleural mesothelioma in an adolescent.

Arango-Tomás E, Algar-Algar FJ, Salvatierra Velázquez A.

Arch Bronconeumol. 2013 May;49(5):218-9. doi: 10.1016/j.arbres.2012.10.005. Epub 2012 Dec 20. English, Spanish. No abstract available.

15.

[Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].

Marco S, Tomasini P, Greillier L, Barlesi F.

Rev Mal Respir. 2011 Dec;28(10):1216-29. doi: 10.1016/j.rmr.2011.04.014. Epub 2011 Nov 4. Review. French.

PMID:
22152931
16.

[Malignant pleural mesothelioma: further options].

van Hezik EJ.

Arch Bronconeumol. 2005 Dec;41(12):703. Spanish. No abstract available.

17.

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

Uramoto H, Onitsuka T, Shimokawa H, Hanagiri T.

Anticancer Res. 2010 Oct;30(10):4309-15.

PMID:
21036757
18.

Chemotherapy for malignant mesothelioma.

Baas P.

Lung Cancer. 2005 Jul;49 Suppl 1:S61-4. Epub 2005 Apr 11. Review. No abstract available.

PMID:
15950803
19.

Malignant mesothelioma.

Muñoz A, Barceló R, López-Vivanco G.

N Engl J Med. 2006 Jan 19;354(3):305-7; author reply 305-7. No abstract available.

PMID:
16422026
20.

Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma.

Gridelli C, Pepe R, Airoma G, Incoronato P, Rossi A, Palazzolo G, Bianco AR.

Tumori. 1992 Dec 31;78(6):380-2.

PMID:
1297232

Supplemental Content

Support Center